Cargando…
A Serum Metabolite Classifier for the Early Detection of Type 2 Diabetes Mellitus-Positive Hepatocellular Cancer
Type 2 diabetes mellitus (T2DM) has been identified as an independent risk factor for hepatocellular cancer (HCC). However, there are no ideal biomarkers for the surveillance and early detection of HCC in the T2DM population at present. In this study, we aimed to explore novel metabolite biomarkers...
Autores principales: | Cao, Lin-Lin, Han, Yi, Pei, Lin, Yue, Zhi-Hong, Liu, Bo-Yu, Cui, Jing-Wen, Jia, Mei, Wang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315765/ https://www.ncbi.nlm.nih.gov/pubmed/35888734 http://dx.doi.org/10.3390/metabo12070610 |
Ejemplares similares
-
Simultaneous Quantification of Serum Lipids and Their Association with Type 2 Diabetes Mellitus-Positive Hepatocellular Cancer
por: Yue, Zhihong, et al.
Publicado: (2023) -
Novel classifiers with clinical laboratory parameters for early detection of osteosarcoma
por: Cao, Lin‐Lin, et al.
Publicado: (2020) -
The Potential of Serum Exosomal hsa_circ_0028861 as the Novel Diagnostic Biomarker of HBV-Derived Hepatocellular Cancer
por: Wang, Yuanxiao, et al.
Publicado: (2021) -
Metabolic Profiling Identified a Novel Biomarker Panel for Metabolic Syndrome-Positive Hepatocellular Cancer
por: Cao, Lin-Lin, et al.
Publicado: (2022) -
Understanding and Classifying Metabolite Space and Metabolite-Likeness
por: Peironcely, Julio E., et al.
Publicado: (2011)